Recent events for Abbott Laboratories (NYSE:ABT) include the integration of Beta Bionics' iLet Bionic Pancreas with Abbott's sensor technology and a partnership with the Department of Health - Abu ...

Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...

Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...

Abbott Laboratories (NYSE:ABT) is one of the best stocks to buy for beginners now. On June 10, Tandem Diabetes Care Inc.

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Abbott remains a Buy at $131 for its steady cash flow, strong fundamentals, and long-term healthcare growth, despite short-term revenue concerns. Wall Street underestimates ABT's operational ...

Abbott Laboratories recently received FDA approval for its Tendyne™ TMVR system, a significant milestone enhancing its cardiovascular product portfolio. Over the past month, Abbott's stock price ...

In the Legislature’s sloppy law attempting to ban cannabis products with THC, the punishment could be worse than the crime. | ...

Abbott’s financial performance has been robust, with the company reporting strong organic growth in recent quarters. In Q4 2024, Abbott achieved approximately 10.1% organic revenue growth ...

Abbott Laboratories' estimated fair value is US$125 based on 2 Stage Free Cash Flow to Equity With US$131 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.